Document p2gXkVod7vqw3860qwqNyKkOk

ATTACHMENT TO LETTER TO C.AUER DATED AUGUST 31,2000 SUPPLEMENTAL SUBMISSION PFOSAA Perfluorooetanesulfonylamido(ethyl)acetate MedicalSurveillancaend Epidemiologic See item I under PFOS: InterimReport #1, Determination of Serum Half-Livesof Several Fluorochemicals,June 8, 2000. Acute Toxicity(BibliographyOnly I . FinalReport,Acute Oral ToxicityStudy in Rats,Hazleton LaboratoriesAmerica, Inc.,Study No. 70905392, 3M Reference No. T-41 01, FC-109 (19-23% PFOSAA Potassium saltin water),January 21, 1988. 2. FinalReport,Acute Dermal ToxicityStudy inRabbits (OECD Guidelines),Hazleton LaboratoriesAmerica, Inc.,Study No. 70905393, 3M Reference No. T-41 01, FC-109 (19-23% PFOSAA Potassium saltin water),January 18, 1988. 3. FinalReport, Primary Dermal Irn*tation/CorrosioSntudy in Rabbits,Hazleton LaboratoriesAmerica, Inc.,Study No. 70905394, 3M Reference No. T-4101, FC-109 (19-23% PFOSAA Potassium saltin water),January 18, 1988. 4. FinalReport,Primary Eye lm'tation/CorrosioSntudy in Rabbits,Hazleton LaboratoriesAmerica, Inc.,Study No. 70905395, 3M Reference No. T-4101, FC-109 (19-23% PFOSAA Potassium saltin water),January 18, 1988. Ongoin Mechanistic researchatthe Universityof Minnesota under the directionof Kendall Wallace includesPFOSAA, 3M Reference No. T-6896. I. Documents regarding this researchhave been previouslysubmitted with the May 4, 2000 submission on PFOS (see Mechanistic 1)(a)-(f)). 9